RxDoctor Payments Data

Lynne Uhl, MD

Anatomic Pathology & Clinical Pathology · Boston, MANPI 1215901319

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 3 manufacturers reported payments, led by Grifols Diagnostic Solutions, Inc. at 53.6% of the total. Reporting peaked in 2021 at $4,575 and has fallen 56.3% since, to $2,000 in 2024. Among anatomic pathology & clinical pathology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,095in general payments, 2019–2025

Across 16 payments — averaging $880.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Grifols Diagnostic Solutions, Inc.$8K
  • Abbott$5K
  • American National Red Cross$2K
$61,804in research payments, 2019–2025

Across 4 payments — averaging $15,451 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cerus Corporation$62K

What the payments were for

  • Consulting fees$6,35045%
  • Speaking & faculty fees$6,20044%
  • Travel & lodging$1,38810%
  • Food & beverage$1571%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Grifols Diagnostic Solutions, Inc.7$7,550
Abbott3$5,000
American National Red Cross6$1,545

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,095 in reported general payments places this provider in the 90th percentile of 196 anatomic pathology & clinical pathology providers in Massachusetts.

See all anatomic pathology & clinical pathology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$28,662
Medicare patients
789
Services billed
1,536

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →